MDCX READ THE FULL V.MDCX RESEARCH REPORT First Patient Randomized for Medicus Pharma’s Phase 2 Clinical Study (SKNJCT-003) ...

Like Warren Buffett and Peter Lynch, Cathie Wood’s art of investing has garnered much attention lately. Wood’s Ark Innovation ...

Ares Capital (ARCC) ended the recent trading session at $20.71, demonstrating a +0.1% swing from the preceding day's closing price. This change lagged the S&P 500's 0.25% gain on the day. On the other ...

Axis Capital Holdings has seen continuous revisions higher to its earnings estimates over the last year and thus currently has a Zacks Rank #1 (Strong Buy) rating. FY24 earnings have climbed by 7% and ...

Core Earnings show Street Earnings fail to account for a material amount of unusual items, which distorts investors’ view of ...

Chicago, IL – September 23, 2024 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec.

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key ...

Zacks All-Cap Core Fund earns an Average Process Pillar rating. The main contributor to the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its ten-year ...

COLUMBUS, Ohio (AP) — COLUMBUS, Ohio (AP) — Worthington Enterprises, Inc. (WOR) on Tuesday reported earnings of $24.3 million in its fiscal first quarter. On a per-share basis, the Columbus, ...

Chicago, IL – September 20, 2024 – Today, Zacks Equity Research discusses Valero Energy VLO, Murphy USA MUSA and Galp Energia ...